Cold Genesys' Series B Round

Cold Genesys raised a round of funding on August 05, 2015.

Cold Genesys is a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition and development of immunotherapies. The company's proprietary agent, CG0070, has the pot…

Articles about Cold Genesys' Series B Round: